Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : lcav -- Ignore unavailable to you. Want to Upgrade?

To: Manny Gugliuzza who wrote (361)	5/7/1998 5:34:00 PM
From: Harry W. Lowe	Read Replies (3) \| Respond to of 942

AR, The sell signal for LCAV, given on 5/6/98, was confirmed today with he price drop to the closing price of $3 1/16 at 240,600 shares. The closing price was off 11/32 pt. (-10.9%). All technical indicators are in a sell configuration. If the price drops below $3.00, a further decline to $2.50 can be expected. Should these prices be penetrated, a test of $2.375 can be expected. Other Excimer Eye Care stocks are in negative price trends as well which does not bode well for the short term price recovery of LCAV. This issue will recover in time and make another test of $4.00, but there will be a period of base building before upside momentum can be regained. Will continue to advise this thread. Harry